Log in to save to my catalogue

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy...

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51df00b5f5fa48b2ba32fe451ceee5e6

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer

About this item

Full title

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-12, Vol.13 (1), p.7802-14, Article 7802

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Neoadjuvant chemoradiotherapy (nCRT) has become the standard treatment for patients with locally advanced rectal cancer (LARC). Therapeutic efficacy of nCRT is significantly affected by treatment-induced diarrhea and hematologic toxicities. Metabolic alternations in cancer therapy are key determinants to therapeutic toxicities and responses, but ex...

Alternative Titles

Full title

Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_51df00b5f5fa48b2ba32fe451ceee5e6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51df00b5f5fa48b2ba32fe451ceee5e6

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-35511-y

How to access this item